CPRX vs. MOH

In the year-to-date period, CPRX achieves a 27.66% return, which is significantly higher than MOH's -18.76% return. Over the past 10 years, CPRX has outperformed MOH with an annualized return of 21.79%, while MOH has yielded a comparatively lower 18.49% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Molina Healthcare, Inc. (MOH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CPRX Sharpe Ratio is 1.08, which is higher than the MOH Sharpe Ratio of -0.48. The chart below compares the historical Sharpe Ratios of CPRX and MOH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither CPRX nor MOH has paid dividends to shareholders.

The maximum CPRX drawdown since its inception was -94.25%, which is greater than MOH's maximum drawdown of -68.37%. Use the drawdown chart below to compare losses from any high point for CPRX and MOH. For additional features, visit the drawdowns tool.

The current volatility for Catalyst Pharmaceuticals, Inc. (CPRX) is 8.90%, while Molina Healthcare, Inc. (MOH) has a volatility of 9.86%. This indicates that CPRX experiences smaller price fluctuations and is considered to be less risky than MOH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Molina Healthcare, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.